We then carried out experiments in a Drosophila model to test whether the “hits” were relevant to C9-ALS and if they were pathological changes or compensatory responses to neurodegeneration, and we integrated these data into a map of pathway changes in C9-ALS patient cells. The gene discussed is C9; the disease is amyotrophic lateral sclerosis.